The burgeoning popularity of semaglutide , initially for diabetes , is creating significant interest within the UK , prompting a notable shift in hormone trends. Availability these medications remains a complex landscape, with NHS provision currently limited and specialist practices offering therapy at a substantial price. Concerns are being rai… Read More